Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | March 14, 2025 05:05pm

Gainers

  • Quantum-Si (NASDAQ:QSI) shares increased by 30.1% to $1.77 during Friday's after-market session. The market value of their outstanding shares is at $280.2 million.
  • HeartSciences (NASDAQ:HSCS) stock rose 8.77% to $3.1. The market value of their outstanding shares is at $3.0 million. As per the press release, Q3 earnings came out yesterday.
  • Revelation Biosciences (NASDAQ:REVB) shares rose 8.52% to $3.69. The company's market cap stands at $3.3 million.
  • Coya Therapeutics (NASDAQ:COYA) shares moved upwards by 7.66% to $6.99. The company's market cap stands at $116.7 million.
  • Senti Biosciences (NASDAQ:SNTI) stock moved upwards by 7.44% to $3.75. The company's market cap stands at $18.1 million.
  • Prelude Therapeutics (NASDAQ:PRLD) shares moved upwards by 7.41% to $0.8. The company's market cap stands at $44.1 million. The company's, Q4 earnings came out 4 days ago.

Losers

  • Aspira Womens Health (NASDAQ:AWH) stock declined by 9.4% to $0.13 during Friday's after-market session. The company's market cap stands at $2.2 million.
  • BioSig Technologies (NASDAQ:BSGM) shares fell 7.1% to $0.57. The market value of their outstanding shares is at $13.5 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) stock decreased by 6.79% to $0.25. The company's market cap stands at $1.7 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares fell 6.56% to $0.42. The market value of their outstanding shares is at $2.6 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock fell 6.49% to $0.35. The company's market cap stands at $1.7 million.
  • Cellectis (NASDAQ:CLLS) stock declined by 6.45% to $1.16. The company's market cap stands at $116.1 million. The company's, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AWH BSGM CLLS COYA HCTI HSCS PRLD PTIX QSI REVB SHPH SNTI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist